SOURCE: ONE Bio, Corp.

January 18, 2011 16:30 ET

ONE Bio Obtains High-Tech Enterprise Certification

MIAMI, FL--(Marketwire - January 18, 2011) - ONE Bio, Corp. ("ONE" or the "Company") (OTCBB: ONBI), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced that its subsidiary, Green Planet Bioengineering, Co., Ltd. through its Chinese operating unit, was granted the designation of high-tech enterprise by the Fujian provincial High-tech Department (Document No.: Fujian High-tech). 

High-tech enterprise designation is achieved by a state supported China resident enterprise (excluding those in Hong Kong, Macao and Taiwan areas) that among other requirements has developed research work, converted the research to production and the developed IP technology forms part of the company's operations and competitive edge.

The honor received by the Company is a statement that it has achieved national level recognition as a high-tech enterprise providing it the ability to receive a 10% tax relief benefit starting in the 2nd quarter of this year. In addition, the Company will benefits from additional tax subsidies related to the production and sell of medicinal plants and agricultural products like sarcandra glabra, polygonum cuspidatum, reishi mushroom and others which are some of the Company's highly sought-after products. The high-tech designation good for 3 years once obtained will reduce the tax rate of the Company starting in the 2nd quarter which will increase the Company's net income for every dollar of pre-tax profit earned by the Company.

"Obtaining the high-tech designation in China is a great achievement for our Company both in terms of customer and general market recognition as well as for financial benefits," stated ONE's CEO Marius Silvasan. "We drive innovation through our in-house R&D team. Our team's research has allowed us to file patents related to various extraction processes that we utilize today throughout our operations. This IP technology has allowed us to be at the forefront of our industry and yield a high gross profit margin on the sale of our raw extracts," added Silvasan.

About ONE Bio, Corp.

ONE Bio, Corp. ("ONE") (OTCBB: ONBI) ( headquartered in Miami, FL, is an innovative company utilizing patented green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on the Asia Pacific region. Key products include widely recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. ONE has experienced solid organic growth driven by a robust demand for its products in China, Japan and the United States.

This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE Bio, Corp. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. These risks and other factors are detailed in the Company's regular filings with the U.S. Securities and Exchange Commission. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and ONE Bio, Corp. does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact Information